← FDA Drug Approvals (Drugs@FDA)
LANGLARA
BLA · Biologics License Application · Sponsor: SUNSHINE LAKE PHARMA CO LTD · Approved 2026-04-29
Drug application
- FDA Application #
BLA761412- Application type
- Biologics License Application
- Brand name
- LANGLARA
- Generic name
- Insulin Glargine-Aldy
- Active ingredients
- INSULIN GLARGINE-ALDY
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SUNSHINE LAKE PHARMA CO LTD
- First approval
- 2026-04-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown